Drug Discovery Approaches Utilizing Three-Dimensional Cell Culture

  • Ryan S
  • Baird A
  • Vaz G
 et al. 
  • 39


    Mendeley users who have this article in their library.
  • 14


    Citations of this article.


Abstract Historically, two-dimensional (2D) cell culture has been the preferred method of producing disease models in vitro. Recently, there has been a move away from 2D culture in favor of generating three-dimensional (3D) multicellular structures, which are thought to be more representative of the in vivo environment. This transition has brought with it an influx of technologies capable of producing these structures in various ways. However, it is becoming evident that many of these technologies do not perform well in automated in vitro drug discovery units. We believe that this is a result of their incompatibility with high-throughput screening (HTS). In this study, we review a number of technologies, which are currently available for producing in vitro 3D disease models. We assess their amenability with high-content screening and HTS and highlight our own work in attempting to address many of the practical problems that are hampering the successful deployment of 3D cell systems in mainstream research.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Sarah-Louise Ryan

  • Anne-Marie Baird

  • Gisela Vaz

  • Aaron J. Urquhart

  • hias Senge

  • Derek J. Richard

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free